Khosrovi Behzad 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Nov 15, 2010
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2008-09-05+35,400→ 272,900 totalExercise: $1.95From: 2009-09-05Exp: 2018-09-05→ Common Stock (35,400 underlying)
Footnotes (2)
- [F1]Original Form 4 filed on September 9, 2008. This amendment is filed to correct the expiration date of the options from September 5, 2019 to September 5, 2018.
- [F2]Original Form 4 filed on September 9, 2008. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 272,900 not 72,900.